Dec 2022: Roy lab members presented at the Annual Meeting of ASCB/EMBO, Washington DC.

Abigail Allen: mini-symposium talk (session: Signaling and Cellular Plasticity) and poster

Dr. David Gau: micro-symposium talk (session: Cellular Microenvironment, building a niche) and poster

Ian Eder: micro-symposium talk (session: Cellular Microenvironment, building a niche) and poster

Andrew Orenberg, Pooja Chawla, and Virginia Yu: Posters

Oct 2022: Roy-Kolarcik research team receives a grant titled "Actin' against ALS" from the Clinical and Translational Science Institute of the University of Pittsburgh as part of the Pitt Innovation Challenge.

Aug 15, 2022: Dr. David Gau receives a NIH K99/R00 grant for his kidney cancer research

Aug 1, 2022: Ian Eder receives a NIH-T32 CATER pre-doctoral fellowship

May 1, 2022: Interdisciplinary team led by Dr. Partha Roy Receives an R21 grant from NIH for small molecule discovery research

Mar 02, 2022: Interdiscilinary team including Dr. Partha Roy receives $60k Pitt momentum teaming grant

Aug 15, 2021: Abigail Allen receives a NIH-F31 pre-doctoral fellowship for her cardiovascular research

Apr 09, 2021: Dr. Partha Roy received an NIH R01 and an award from the Magee Women's Cancer Research

May 21, 2021: Abigail Allen receives AHA Fellowship for her cardiovascular research

Nov 13, 2020: Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells manuscript was published by JBC

Oct 21, 2020: Roy Lab research featured in JBC special virtual issue

Sept 1, 2020: Dr. David Gau receives a NIH-T32 postdoctoral fellowship for his kidney cancer research

July 10, 2020: Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization manuscript was published by JBC

May 18, 2020: Dr. David Gau receives National Cancer Center Fellowship for Kidney Cancer Research